Skip to main content
Loading

EosDx Inc.

February 26, 2024
Diagnostics
EosDx Inc.
EosDx is creating a new modality for AI-driven cancer detection using Bio-crystallography that identifies cancer biomarkers in tissue using a non-invasive, safe, accurate, and objective test
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP